We are live on ! Find out more
OCGN icon

Ocugen

115 hedge funds and large institutions have $79.1M invested in Ocugen in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

49% more call options, than puts

Call options by funds: $855K | Put options by funds: $575K

14% more funds holding

Funds holding: 101115 (+14)

1.51% more ownership

Funds ownership: 26.18%27.68% (+1.5%)

24% less capital invested

Capital invested by funds: $104M → $79.1M (-$25.3M)

Holders
115
Holders Change
+14
Holders Change %
+13.86%
% of All Funds
1.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
35
Reduced
22
Closed
17
Calls
$855K
Puts
$575K
Net Calls
+$280K
Net Calls Change
-$1.05M

OCGN Hedge Fund Activity: Q3 2024 in Review

115 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q3 2024, worth a combined $79.1M — down 24% from $104M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new OCGN positions and 17 closed out — a net gain of 14 holders — while 35 added to existing stakes and 22 trimmed.

The largest buyer was GMT Capital, opening a new position worth an estimated $3.37M. The largest seller was Rafferty Asset Management, cutting an estimated $384K.

  • 115 institutional investors held Ocugen (OCGN) as of Q3 2024, up from 101 in Q2 2024.
  • Funds reported $79.1M of Ocugen stock for Q3 2024, down 24% quarter-over-quarter.
  • 31 funds opened new Ocugen positions in Q3 2024 and 17 closed out, a net change of +14 holders.
  • The largest Ocugen buyer in Q3 2024 was GMT Capital, an estimated $3.37M added.
  • The largest Ocugen seller in Q3 2024 was Rafferty Asset Management, an estimated $384K sold.

Based on aggregated 13F filings for Q3 2024.